Showing results (121-130 of 453) with videos related to
Sort By:
Pageof 46
European Journal of Pharmacology|April 20, 2004
The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitationsKate V Allen, Brian M Frier, Mark W J StrachanEuropean Journal of Nuclear Medicine|September 1, 1995
Three-dimensional visualisation of the large bowel: a potential tool for assessing targeted drug delivery and colonic pathologyA C Perkins, C Mann, C G WilsonInternational Journal of Pharmaceutics|February 13, 2001
Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfateS J Jackson, D Bush, A C PerkinsJournal of Pediatric Surgery|May 1, 1996
Peroperative (123)I-MIBG scan using a sterile probe for staging and resection of neuroblastoma in childrenA Aslam, A C Perkins, R D SpicerDiabetes Care|July 1, 1996
Altered taste sensation in newly-diagnosed NIDDMP Perros, T W MacFarlane, C Counsell, et al.Cancer Research|November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein doseA C van Hof, C F Molthoff, Q Davies, et al.Diabetes Care|January 28, 2003
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetesAndrew J Sommerfield, Ian J Deary, Vincent McAulay, et al.Diabetes Care|July 1, 1991
Effects of adrenergic blockade on serum potassium changes in response to acute insulin-induced hypoglycemia in nondiabetic humansB M Fisher, I Thomson, D A Hepburn, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1989
Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetesB M Fisher, P H Baylis, S Thornton, et al.European Journal of Nuclear Medicine|January 1, 1991
Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodiesM V Pimm, R S Rajput, M Frier, et al.Pageof 46